NCT03643744 2024-12-19
Photodynamic Therapy-Induced Immune Modulation: Part III
Wright State University
Phase 1 Terminated
Clinical Trials
11 trialsNCT04809662 2024-11-07
Comparing Immune Responses to Topical Imiquimod
University of California, Davis
Terminated
NCT03963102 2024-07-26
Duration of Ameluz Application in Acral Actinic Keratoses Response
Royal Cornwall Hospitals Trust
Phase 4 Terminated
NCT01525329 2022-03-15
Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease
The Cleveland Clinic
Phase 3 Terminated
NCT03996252 2020-12-07
Combination Topical Therapy for Treatment of Scalp Actinic Keratoses
Tulane University
Phase EARLY_PHASE1 Terminated
NCT02150863 2019-11-18
Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
Massachusetts General Hospital
Phase NA Terminated
NCT02473848 2018-07-19
IMOT001
University of Zurich
Phase 3 Terminated
NCT03076918 2018-05-18
Flexithera
University Hospital, Lille
Phase NA Terminated
NCT01538901 2017-09-12
AKtransplant
Medical University of Vienna
Phase 4 Terminated
NCT00524485 2017-06-14
Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
Roswell Park Cancer Institute
Phase NA Terminated
NCT01203878 2014-12-08
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Tennessee Clinical Research Center
Phase 4 Terminated